|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00501007 |
The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in both diagnostic categories (schizophrenia and no schizophrenia) will predict tobacco dependence treatment outcome at one and six months. It is also hypothesized that smokers with schizophrenia will show lower levels of task persistence after controlling for other motor skills than smokers without schizophrenia.
Condition | Phase |
Tobacco Dependence |
Phase I |
MedlinePlus related topics: | Schizophrenia |
Study Type: | Observational |
Study Design: | Longitudinal, Defined Population, Prospective Study |
Official Title: | Predictors of Treatment Outcome for Smokers With and Without Schizophrenia |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Marc L. Steinberg, PH.D. | 732-235-3362 | marc.steinberg@umdnj.edu |
United States, New Jersey | |||||
UMDNJ Tobacco Dependence Clinic | Recruiting | ||||
New Brunswick, New Jersey, United States, 08901 |
Principal Investigator: | Marc L. Steinberg, PH.D | University of Medicine and Dentistry New Jersey |
Study ID Numbers: | K23 DA018203 |
First Received: | July 11, 2007 |
Last Updated: | July 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00501007 |
Health Authority: | United States: Federal Government |
|
|